List of Novelmed Therapeutics Inc patents

Patent 10183989 was granted and assigned to Novelmed Therapeutics Inc on January, 2019 by the United States Patent and Trademark Office.

Patent 10131706 was granted and assigned to Novelmed Therapeutics Inc on November, 2018 by the United States Patent and Trademark Office.

Patent 9988441 was granted and assigned to Novelmed Therapeutics Inc on June, 2018 by the United States Patent and Trademark Office.

Patent 9926366 was granted and assigned to Novelmed Therapeutics Inc on March, 2018 by the United States Patent and Trademark Office.

Patent 9243070 was granted and assigned to Novelmed Therapeutics Inc on January, 2016 by the United States Patent and Trademark Office.

Patent 9243060 was granted and assigned to Novelmed Therapeutics Inc on January, 2016 by the United States Patent and Trademark Office.

Patent 7959919 was granted and assigned to Novelmed Therapeutics Inc on June, 2011 by the United States Patent and Trademark Office.

Patent 9676842 was granted and assigned to Novelmed Therapeutics Inc on June, 2017 by the United States Patent and Trademark Office.

Patent 8435512 was granted and assigned to Novelmed Therapeutics Inc on May, 2013 by the United States Patent and Trademark Office.

Patent 9023831 was granted and assigned to Novelmed Therapeutics Inc on May, 2015 by the United States Patent and Trademark Office.

Patent 9566297 was granted and assigned to Novelmed Therapeutics Inc on February, 2017 by the United States Patent and Trademark Office.

Patent 9040507 was granted and assigned to Novelmed Therapeutics Inc on May, 2015 by the United States Patent and Trademark Office.

Patent 8680075 was granted and assigned to Novelmed Therapeutics Inc on March, 2014 by the United States Patent and Trademark Office.

Patent 9816999 was granted and assigned to Novelmed Therapeutics Inc on November, 2017 by the United States Patent and Trademark Office.

Patent 8940490 was granted and assigned to Novelmed Therapeutics Inc on January, 2015 by the United States Patent and Trademark Office.

Patent 10696740 was granted and assigned to Novelmed Therapeutics Inc on June, 2020 by the United States Patent and Trademark Office.

Patent 10711056 was granted and assigned to Novelmed Therapeutics Inc on July, 2020 by the United States Patent and Trademark Office.

Patent 10858420 was granted and assigned to Novelmed Therapeutics Inc on December, 2020 by the United States Patent and Trademark Office.

Patent 11981727 was granted and assigned to Novelmed Therapeutics Inc on May, 2024 by the United States Patent and Trademark Office.